 Oncogene Proteins v-abl
"Oncogene Proteins v-abl" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transforming proteins encoded by the abl oncogenes. Oncogenic transformation of c-abl to v-abl occurs by insertional activation that results in deletions of specific N-terminal amino acids.
| Descriptor ID |
D016374
|
| MeSH Number(s) |
D12.776.624.664.520.750.875 D12.776.964.700.750.875 D12.776.964.775.750.875
|
| Concept/Terms |
Oncogene Proteins v-abl- Oncogene Proteins v-abl
- Oncogene Proteins v abl
- Proteins v-abl, Oncogene
- v-abl, Oncogene Proteins
- v-abl Proteins
- v abl Proteins
- abl Oncogene Proteins
- Oncogene Proteins, abl
- Oncogene Products v-abl
- Oncogene Products v abl
- Products v-abl, Oncogene
- v-abl, Oncogene Products
|
Below are MeSH descriptors whose meaning is more general than "Oncogene Proteins v-abl".
Below are MeSH descriptors whose meaning is more specific than "Oncogene Proteins v-abl".
This graph shows the total number of publications written about "Oncogene Proteins v-abl" by people in this website by year, and whether "Oncogene Proteins v-abl" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Oncogene Proteins v-abl" by people in Profiles.
-
Schmoker AM, Weinert JL, Kellett KJ, Johnson HE, Joy RM, Weir ME, Ebert AM, Ballif BA. Dynamic multi-site phosphorylation by Fyn and Abl drives the interaction between CRKL and the novel scaffolding receptors DCBLD1 and DCBLD2. Biochem J. 2017 11 21; 474(23):3963-3984.
-
Scott AJ, Song EK, Bagby S, Purkey A, McCarter M, Gajdos C, Quackenbush KS, Cross B, Pitts TM, Tan AC, Eckhardt SG, Fenton H, Arcaroli J, Messersmith WA. Evaluation of the efficacy of dasatinib, a Src/Abl inhibitor, in colorectal cancer cell lines and explant mouse model. PLoS One. 2017; 12(11):e0187173.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|